David C. Evans to Join BOD at Cardinal Health

June 26, 2020

David C. Evans has been elected as an independent director, effective July 1. The news was announced by Cardinal Health.

David C. Evans brings decades of financial expertise and strong, diverse board experiences.

Most recently, David C. Evans served as interim Chief Financial Officer for Cardinal Health for approximately nine months. He previously held the role of Chief Financial Officer of Battelle Memorial Institute, one of the largest private, non-profit research organizations in the world. Prior to that, Mr. Evans served as Executive Vice President and Chief Financial Officer of The Scotts MiracleGro Company, the leading manufacturer and marketer of branded consumer lawn and garden products in North America.

Currently, Mr. Evans serves on the board of directors for Scotts MiracleGro and is a member of both the audit committee and the compensation and organization committee. He also serves on the board of directors for the Siegel Rare Neuroimmune Association and formerly served as a board member on the finance and audit committee for Ohio Health.

“We are pleased to welcome Dave as a director,” said Gregory Kenny, Chairman of the Board for Cardinal Health. “The Board has been impressed by both his operational instincts and his financial acumen. Dave sees both the big picture, as well as the value drivers, while never losing sight of our mission – being essential to care. We look forward to benefitting from his history as a strong and independent-minded leader as we continue to navigate this time of immense change and adapt our growth strategies for the future.”

Mr. Evans holds a Bachelor of Science in Business Administration degree in Accounting from The Ohio State University.

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.